Charles River Laboratories (CRL)
Stock-Based Compensation
$19.78M
Quarterly · Period ending: · USD
CRL Stock-Based Compensation
Latest reported$19.78Mperiod ending
Latest reported$19.78Mperiod ending
CRL Quarterly Stock-Based Comp ($0.00 → $19.78M)
Quarterly stock-based compensation
High-resolution chart · PNG
CRL stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 19,781,000 | |
| 22,381,000 | |
| 0 | |
| 23,267,000 | |
| 17,049,000 | |
| 13,135,000 | |
| 17,235,000 | |
| 19,331,000 | |
| 16,587,000 | |
| 16,738,000 | |
| 19,521,000 | |
| 22,797,000 | |
| 16,270,000 | |
| 13,460,000 | |
| 22,069,000 | |
| 21,999,000 | |
| 14,930,000 | |
| 14,619,000 | |
| 19,185,000 | |
| 22,023,000 | |
| 17,077,000 | |
| 13,189,000 | |
| 15,368,000 | |
| 16,870,000 | |
| 13,143,000 | |
| 10,960,000 | |
| 13,842,000 | |
| 14,025,000 | |
| 16,505,000 | |
| 12,899,000 | |
| 11,438,000 | |
| 11,820,000 | |
| 13,547,000 | |
| 10,541,000 | |
| 11,101,000 | |
| 11,526,000 | |
| 11,890,000 | |
| 9,486,000 | |
| 10,995,000 | |
| 10,600,000 | |
| 12,106,000 | |
| 9,941,000 | |
| 9,773,000 | |
| 10,476,000 | |
| 10,199,000 | |
| 9,674,000 | |
| 7,903,000 | |
| 8,251,000 | |
| 8,222,000 | |
| 6,659,000 | |
| 6,311,000 | |
| 6,047,000 | |
| 6,280,000 | |
| 5,904,000 | |
| 6,027,000 | |
| 5,242,000 | |
| 5,320,000 | |
| 5,266,000 | |
| 15,787,000 | |
| 0 | |
| 0 | |
| 5,919,000 | |
| 4,083,000 | |
| 6,771,000 | |
| 7,768,000 | |
| 6,856,000 | |
| 5,681,000 | |
| 5,999,000 | |
| 6,464,000 | |
| 5,669,000 | |
| 18,012,000 | |
| 5,533,000 | |
| 6,619,000 | |
| 6,321,000 | |
| 0 | |
| 0 | |
| 0 | |
| 5,455,000 | |
| -45,834,000 | |
| 0 | |
| 0 | |
| 5,505,000 | |
| 16,974,000 | |
| 0 | |
| 0 | |
| 4,158,000 | |
| 3,217,000 | |
| 0 | |
| 0 | |
| 598,000 | |
| 1,102,000 | |
| 0 | |
| 0 | |
| 97,000 | |
| 0 | |
| 0 | |
| 0 | |
| -6,220,000 | |
| 4,467,000 | |
| 0 |